Author

G. W. Schwartz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1

Frequent Co-Authors

A. Bigdeli· 1 shared A. G. Aguilar-Navarro· 1 shared A. G. X. Zeng· 1 shared A. Lehman· 1 shared A. Murison· 1 shared A. Perl· 1 shared B. Manning· 1 shared B. Wang· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bigdeli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Identification of a human hematopoietic stem cell subset that retains memory of inflammatory stress

A. G. X. Zeng, M. S. Nagree, N. A. Jakobsen, S. Shah, A. Murison, J.-G. Cheong, S. Turkalj, I. Lim, L. Jin, J. Araujo, A. G. Aguilar-Navarro, D. Parris, J. McLeod, H. Kim, H. S. Lee, , S. Z. Xie

The paper identifies a human HSC subset with inflammatory memory that accumulates with age and clonal hematopoiesis, potentially increasing cancer and infection risks.

bioRxiv · Sep 11, 2023 · PreprintCell Biology

CDK5 activity in retinal pigment epithelium contributes to gap junction dynamics during phagocytosis

J. Fadjukov, S. Wienbar, N. Milicevic, S. Hakanen, M. Vihinen-Ranta, T. O. Ihalainen, G. W. Schwartz, S. Nymark

This study investigates how CDK5 activity influences gap junction dynamics and phagocytosis in retinal pigment epithelium through Cx43 phosphorylation.

bioRxiv · Feb 9, 2023 · PreprintCell Biology

Classes of ITD predict outcomes in patients with AML treated with FLT3 inhibitors

G. W. Schwartz, B. Manning, Y. Zhou, P. Velu, A. Bigdeli, R. Astles, A. Lehman, J. Morrissette, A. Perl, M. Carroll, R. Faryabi

The paper classifies FLT3-ITD mutations into typical and atypical based on nucleotide composition and shows typical ITD carriers have better outcomes with FLT3 inhibitors.

bioRxiv · May 14, 2018Cancer Biology